BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 36098126)

  • 21. International phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26.
    Sztankay M; Aaronson NK; Arraras JI; Basso U; Bumbasirevic U; Efficace F; Giesinger JM; Johnson CD; van Leeuwen M; Oberguggenberger AS; Sosnowski R; Young T; Holzner B;
    BMC Cancer; 2018 Nov; 18(1):1104. PubMed ID: 30419889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validity and reliability of the Italian version of the ECOS-16 questionnaire in postmenopausal women with prevalent vertebral fractures due to osteoporosis.
    Salaffi F; Malavolta N; Cimmino MA; Di Matteo L; Scendoni P; Carotti M; Stancati A; Mulé R; Frigato M; Gutierrez M; Grassi W;
    Clin Exp Rheumatol; 2007; 25(3):390-403. PubMed ID: 17631735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the shortened Hunter Syndrome-Functional Outcomes for Clinical Understanding Scale (HS-FOCUS).
    Mattera M; Vernon MK; Raluy-Callado M; Mikl J
    Health Qual Life Outcomes; 2018 Nov; 16(1):209. PubMed ID: 30409228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Validation of the QFS measuring the frequency and satisfaction in social behaviours in psychiatric adult population].
    Zanello A; Weber Rouget B; Gex-Fabry M; Maercker A; Guimon J
    Encephale; 2006; 32(1 Pt 1):45-59. PubMed ID: 16633290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study.
    Koller M; Shamieh O; Hjermstad MJ; Hornslien K; Young T; Chalk T; Ioannidis G; Harle A; Johnson CD; Tomaszewski KA; Serpentini S; Pinto M; van der Weijst L; Janssens A; Morag O; Chie WC; Arraras JI; Pompili C; Jungraithmayr W; Hechtner M; Katsochi D; Müller K; Gräfenstein L; Schulz C; Bottomley A; ; ;
    Lancet Oncol; 2020 May; 21(5):723-732. PubMed ID: 32213338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of the Japanese version of cognitive flexibility scale.
    Oshiro K; Nagaoka S; Shimizu E
    BMC Res Notes; 2016 May; 9():275. PubMed ID: 27188498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Questionnaire to assess quality of life in patients with breast cancer - Validation of the Chinese version of the EORTC QLQ-BR 53.
    Zhang Z; Zhang X; Wei L; Lin Y; Wu D; Xie S; Yue L; Tian J; Zhang Y; Song Q; Woo SM; Miller AR; Luo L; Zhang L
    Breast; 2017 Apr; 32():87-92. PubMed ID: 28068605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S; Jayasekara P; Abeysinghe P; Hjermstad M; Lalloo R
    BMC Oral Health; 2022 Aug; 22(1):359. PubMed ID: 35986341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reliability and validity of the Japanese version of the Recovery Assessment Scale (RAS) for people with chronic mental illness: scale development.
    Chiba R; Miyamoto Y; Kawakami N
    Int J Nurs Stud; 2010 Mar; 47(3):314-22. PubMed ID: 19679304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and validation of a patient reported outcome measure for health-related quality of life for locally recurrent rectal cancer: a multicentre, three-phase, mixed-methods, cohort study.
    Harji DP; Koh C; McKigney N; Solomon MJ; Griffiths B; Evans M; Heriot A; Sagar PM; Velikova G; Brown JM
    EClinicalMedicine; 2023 May; 59():101945. PubMed ID: 37256101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Patient-Reported Outcomes Thermometer-5-Item Scale (5T-PROs): Validation of a New Tool for the Quick Assessment of Overall Health Status in Painful Rheumatic Diseases.
    Salaffi F; Di Carlo M; Carotti M; Farah S
    Pain Res Manag; 2018; 2018():3496846. PubMed ID: 30425755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30): validation study of the Thai version.
    Silpakit C; Sirilerttrakul S; Jirajarus M; Sirisinha T; Sirachainan E; Ratanatharathorn V
    Qual Life Res; 2006 Feb; 15(1):167-72. PubMed ID: 16411041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing quality of life in palliative care settings: head-to-head comparison of four patient-reported outcome measures (EORTC QLQ-C15-PAL, FACT-Pal, FACT-Pal-14, FACT-G7).
    King MT; Agar M; Currow DC; Hardy J; Fazekas B; McCaffrey N
    Support Care Cancer; 2020 Jan; 28(1):141-153. PubMed ID: 30993452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hearing Impairment Impact-Significant Other Profile (HII-SOP): a tool to measure hearing loss-related quality of life in spouses of people with hearing loss.
    Preminger JE; Meeks S
    J Am Acad Audiol; 2012; 23(10):807-23. PubMed ID: 23169197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functioning in the fibromyalgia syndrome: validity and reliability of the WHODAS 2.0.
    Barreto MCA; Moraleida FRJ; Graminha CV; Leite CF; Castro SS; Nunes ACL
    Adv Rheumatol; 2021 Sep; 61(1):58. PubMed ID: 34530930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.
    Singer S; Amdal CD; Hammerlid E; Tomaszewska IM; Castro Silva J; Mehanna H; Santos M; Inhestern J; Brannan C; Yarom N; Fullerton A; Pinto M; Arraras JI; Kiyota N; Bonomo P; Sherman AC; Baumann I; Galalae R; Fernandez Gonzalez L; Nicolatou-Galitis O; Abdel-Hafeez Z; Raber-Durlacher J; Schmalz C; Zotti P; Boehm A; Hofmeister D; Krejovic Trivic S; Loo S; Chie WC; Bjordal K; Brokstad Herlofson B; Grégoire V; Licitra L;
    Head Neck; 2019 Jun; 41(6):1725-1737. PubMed ID: 30636188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers.
    Salas M; Henderson M; Wientzek-Fleischmann A; Islam Z; Tu N; Bilitou A; Elsharkawy M; Stellmacher U
    Front Pharmacol; 2020; 11():1109. PubMed ID: 32792948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychometric evaluation of a patient-reported outcomes instrument for congenital thrombotic thrombocytopenic purpura.
    Oladapo A; Ito D; Rodriguez AM; Philpott S; Krupnick R; Allen V; Hibbard C; Scully M; Ewenstein B
    J Patient Rep Outcomes; 2023 Jul; 7(1):68. PubMed ID: 37450201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Health-related quality of life in young adults in education, employment, or training: development of the Japanese version of Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales Young Adult Version.
    Kaneko M; Sato I; Soejima T; Kamibeppu K
    Qual Life Res; 2014 Sep; 23(7):2121-31. PubMed ID: 24526295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.